Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.58 USD | +1.00% | -3.93% | +16.34% |
05-08 | Oppenheimer Adjusts IDEAYA Biosciences Price Target to $53 From $50, Maintains Outperform Rating | MT |
05-07 | IDEAYA Biosciences Shares Fall After Q1 Loss | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.34% | 3.12B | |
+23.26% | 44.96B | |
+0.37% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.88% | 26.08B | |
-21.04% | 19.03B | |
+6.33% | 12.75B | |
+29.20% | 12.06B | |
-3.56% | 11.75B |
- Stock Market
- Equities
- IDYA Stock
- News IDEAYA Biosciences, Inc.
- Wedbush Adjusts Price Target on IDEAYA Biosciences to $35 From $30, Maintains Outperform Rating